Compugen (CGEN) Current Deferred Revenue (2009 - 2026)
Compugen's (CGEN) quarterly Current Deferred Revenue came in at $11.6 million in Q1 2026, up 20.49% year-on-year from $9.6 million in Q1 2025, and up 5.72% quarter-over-quarter from $11.0 million in Q4 2025.
Compugen (CGEN) Current Deferred Revenue (2009 - 2026) Analysis & Trends
Compugen has disclosed Current Deferred Revenue across 10 years of filings, most recently posting $11.6 million for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $11.6 million, up 20.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (up 20.49% YoY), and the FY2025 annual result was $11.0 million, up 13.89% from the prior year.
- Current Deferred Revenue came in at $11.6 million for Q1 2026 at Compugen, up from $11.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $29.6 million in Q2 2025 to a low of $9.6 million in Q1 2025.
- The 4-year median for Current Deferred Revenue is $11.1 million (2023), against an average of $13.1 million.
- Peak annual rise in Current Deferred Revenue reached 162.99% in 2025, while the deepest fall reached 32.92% in 2025.
- Compugen's Current Deferred Revenue stood at $11.1 million in 2023, then slipped by 13.61% to $9.6 million in 2024, then grew by 13.89% to $11.0 million in 2025, then advanced by 5.72% to $11.6 million in 2026.
- The last three Current Deferred Revenue figures came in at $11.6 million (Q1 2026), $11.0 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 10.68 Mn |
| Jun 30, 2025 | 29.59 Mn |
| Mar 31, 2025 | 9.63 Mn |
| Dec 31, 2024 | 9.63 Mn |
| Sep 30, 2024 | 15.91 Mn |
| Jun 30, 2024 | 11.25 Mn |
| Mar 31, 2024 | 10.76 Mn |
| Dec 31, 2023 | 11.15 Mn |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 123,000.00 |
| Mar 31, 2016 | 219,000.00 |
| Dec 31, 2015 | 312,000.00 |
| Sep 30, 2015 | 824,000.00 |
| Jun 30, 2015 | 1.05 Mn |
| Mar 31, 2015 | 1.28 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 2.02 Mn |
| Jun 30, 2014 | 3.12 Mn |